P&G Health Brings Together Leading Health Experts to Tackle Anemia


P&G Health, the health care division of The Procter & Gamble Company, hosted the kick-off of the ‘P&G Blood Health Forum’ over the weekend in Singapore.

The virtual series of medical education sharing sessions brought together internationally recognised experts to address the public health challenge that anemia continues to pose around the world, especially in Asia.

Today, approximately 2.3 billion people suffer from anemia, with an estimated one in two attributed to iron deficiency anemia (IDA) and experiencing symptoms like frequent tiredness, dizziness, paleness, impaired immunity, thus impacting their quality of life and productivity.

Read Also: Allianz Offers COVID-19 Protection for SMEs and Its Employees

Southeast Asia and Africa continue to report the highest prevalence rates of anemia, accounting for 85 percent of global reported cases. The ‘P&G Blood Health Forum’ aims to provide an educational platform for healthcare professionals where they can benefit from exposure to the latest scientific research and clinical insights in the prevention, diagnosis and treatment of iron deficiency anemia.

Held virtually across seven countries in Asia, this year’s opening session was themed ‘Pioneering blood health through early diagnosis and management of iron and micronutrient deficiency’. The discussion sessions, led by an international speaker faculty of leading experts in the fields of anemia, public health, iron physiology and nutritional health, covered a wide breadth of topics on the diagnosis, communication and management of iron deficiency and anemia in patients.

Importantly these topics were contextualized against the current global SARs-COV-2 pandemic. Drawing upon relevant, recent research exploring the potential role of red blood cell dynamics and iron homeostasis in the clinical presentation of COVID-19, the forum offered insights into physiological and clinical considerations for patient management in the new normal.

Read Also: Artificially Sweetened Drinks May Not be Heart Healthier Than Sugary Drinks

Aalok Agrawal, Senior Vice President, P&G Health – Asia Pacific, Middle East and Africa, said, “Anemia continues to be a public health issue around the world today, with some of the highest prevalence rates in Southeast Asia and Africa. Furthermore, it is a health risk that disproportionately affects some of our most vulnerable segments of society – women and children.”

“With the P&G Blood Health Forum, we are heartened to be welcoming some of the world’s leading experts in the field of anemia, iron physiology and nutritional health, to exchange insights and work together to tackle the global anemia health problem.”

“By providing a platform for the fruitful exchange of scientific research and clinical insights, we hope to nurture better awareness of the most effective approaches and tools in fighting anemia.”

Read Also: Over 80 Per Cent of COVID-19 Patients Have Vitamin D Deficiency, Study Finds

Prof. Dr. Zulfiqar A. Bhutta, Robert Harding Inaugural Chair in Global Child Health, Hospital for Sick Children and Co-Director of the SickKids Centre for Global Child Health (Canada) said “Despite sufficient evidence as to the burden and epidemiology of anemia and iron deficiency among children and women of reproductive age in various parts of the world, progress in terms of mitigation strategies remains slow and is associated with significant loss in human capital.”

“These challenges have been made worse by the COVID-19 pandemic and its myriad economic consequences. Addressing these systematically through improved diagnostic measures and appropriate interventions should become a global priority”.

“The full potential of several of the linked sustainable development goals for nutrition, health and learning (SDGs 2, 3 and 4) cannot be realized without addressing iron deficiency anemia at scale, especially among the marginalized and ultra poor populations of the world.”

Read Also: Hologic Champions Early Detection of Breast Cancer Through Proactive Screening

As part of this initiative, P&G Health also announced a strategic partnership with the ‘Asia & Oceania Federation of Obstetrics & Gynecology’ (AOFOG) whom it will be collaborating with on future professional and public health initiatives. This includes a series of ‘Blood Health Forum’ virtual sessions covering topics designed to educate, raise awareness and ultimately support better patient outcomes.

The forum was attended by more than 2,500 participants across Asia’s healthcare sector, including healthcare professionals from Malaysia, India, Indonesia and the Philippines.

The 2020 P&G Blood Health Forum marks the second edition of P&G Health’s International Convention on Iron Deficiency and Anemia, as part of P&G Health’s continued aim to empower consumers to live longer, healthier and more vibrant lives.

Read Also: Ferne Health Launches Singapore’s First Online Sexual Health Platform Providing Home-Based STI Screening Kit

Leave a Reply

Your email address will not be published. Required fields are marked *